Official Title
A PHASE 2/3, INTERVENTIONAL SAFETY, PHARMACOKINETICS, AND EFFICACY, OPEN-LABEL, MULTI-CENTER, SINGLE-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332 (NIRMATRELVIR)/RITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID-19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE
Brief Summary

The purpose of this clinical trial is to learn about the safety, pharmacokinetics(pharmacokinetics helps us understand how the drug is changed and eliminated from yourbody after you take it), and efficacy (how well a study treatment works in the study) ofthe study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirusdisease 2019 (COVID-19).The study medicine will be given to patients under 18 years of age with COVID-19 that arenot hospitalized but are at risk for severe disease.

Detailed Description

Not Provided

Recruiting
COVID-19

Drug: nirmatrelvir

PF-07321332

Drug: ritonavir

ritonavir

Eligibility Criteria

Inclusion criteria:

- Male and female, age 0 to < 18 years, able to swallow for some participants

- Confirmed SARS-CoV-2 infection within 72 hours prior to enrollment

- Initial onset of COVID-19 signs/symptoms within 5 days prior to the day of
enrollment and at least 1 of the specified COVID-19 signs/symptoms present at
enrollment

- Has at least 1 characteristic or underlying medical condition associated with an
increased risk of developing severe illness from COVID-19

Exclusion Criteria:

- History of or need for hospitalization for the medical treatment of COVID-19

- Total bilirubin >=2X upper limit of normal (ULN) (except for Gilbert's syndrome)

- Receiving dialysis or have known moderate to severe renal impairment

- Suspected or confirmed concurrent active systemic infection other than COVID-19

- History of hypersensitivity or other contraindication to any of the components of
the study intervention

- Current or expected use of any medications or substances that are highly dependent
on CYP3A4 for clearance or strong inducers of cytochrome P450 (CYP)3A4

- Has received or is expected to receive antibody treatment, antiviral treatment or
convalescent COVID-19 plasma

- Participating in another interventional clinical study with an investigational
compound or device, including those for COVID-19 through the study follow up

- Females who are pregnant or breastfeeding

Eligibility Gender
All
Eligibility Age
Minimum: 0 Years ~ Maximum: 17 Years
Countries
Bulgaria
Hungary
Japan
Mexico
Puerto Rico
South Africa
United Kingdom
United States
Locations

University of Alabama at Birmingham - School of Medicine
Birmingham, Alabama, United States

Phoenix Children's Hospital
Phoenix, Arizona, United States

Arkansas Children's Hospital
Little Rock, Arkansas, United States

Children's Hospital Los Angeles
Los Angeles, California, United States

Kaiser Permanente
Los Angeles, California, United States

The Regents of the University of California - Los Angeles (UCLA Pediatrics)
Los Angeles, California, United States

UCLA David Geffen School of Medicine
Los Angeles, California, United States

UCLA
Los Angeles, California, United States

Children's Hospital of Orange County
Orange, California, United States

Connecticut Children's Medical Center
Hartford, Connecticut, United States

Children's National Medical Center
Washington, District of Columbia, United States

Life Spring Research Foundation
Miami, Florida, United States

Clinical Site Partners, Inc.
Winter Park, Florida, United States

Children's Healthcare of Atlanta - Arthur M. Blank Hospital
Atlanta, Georgia, United States

Children's Healthcare of Atlanta - Egleston Hospital
Atlanta, Georgia, United States

Children's Healthcare of Atlanta - Arthur M. Blank Hospital
Atlanta, Georgia, United States

Rophe Adult and Pediatric Medicine/SKYCRNG
Union City, Georgia, United States

SKY Clinical Research Network Group-Blake
Union City, Georgia, United States

Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States

University of Chicago Medical Center
Chicago, Illinois, United States

Norton Children´s Hospital
Louisville, Kentucky, United States

Novak Center for Children's Health
Louisville, Kentucky, United States

Louisiana State University Health Sciences Shreveport
Shreveport, Louisiana, United States

Johns Hopkins Hospital
Baltimore, Maryland, United States

Boston Medical Center
Boston, Massachusetts, United States

University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States

Wayne Pediatrics
Detroit, Michigan, United States

Childrens Hospitals and Clinics of Minnesota
Minneapolis, Minnesota, United States

SKY Clinical Research Network Group-Quinn
Ridgeland, Mississippi, United States

SKY Integrative Medical Center/SKYCRNG
Ridgeland, Mississippi, United States

St. Louis Children's Hospital
Saint Louis, Missouri, United States

Washington University School of Medicine
Saint Louis, Missouri, United States

Washington University
Saint Louis, Missouri, United States

Children's Hospital & Medical Center
Omaha, Nebraska, United States

Hackensack University Medical Center
Hackensack, New Jersey, United States

Rutgers University
New Brunswick, New Jersey, United States

University of New Mexico Hospital, COVID-19 Research Clinic
Albuquerque, New Mexico, United States

University of New Mexico Clinical and Translational Science Center
Albuquerque, New Mexico, United States

Suny University at Buffalo
Buffalo, New York, United States

Advanced Specialty Care
Commack, New York, United States

Stony Brook Medicine Clinical Research Center
East Setauket, New York, United States

Cohen Children's Medical Center
New Hyde Park, New York, United States

Columbia University Irving Medical Center
New York, New York, United States

Stony Brook University
Stony Brook, New York, United States

Upstate Health Care Center
Syracuse, New York, United States

Crouse Physicians Office Building
Syracuse, New York, United States

SUNY Upstate Medical University
Syracuse, New York, United States

Upstate Golisano Children's Hospital
Syracuse, New York, United States

Clinical and Translational Research Center
Chapel Hill, North Carolina, United States

investigational Drug Services Pharmacy, UNC Hospitals
Chapel Hill, North Carolina, United States

UNC Children's Hospital
Chapel Hill, North Carolina, United States

UNC Global Clinical Research North
Chapel Hill, North Carolina, United States

University of North Carolina Medical Center
Chapel Hill, North Carolina, United States

Duke Vaccine And Trials Unit
Durham, North Carolina, United States

Duke University - Main Hospital and Clinics
Durham, North Carolina, United States

UNC Children's Raleigh
Raleigh, North Carolina, United States

University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States

UH Landerbrook Health Center
Mayfield Heights, Ohio, United States

UH Parma Medical Center
Parma, Ohio, United States

Oklahoma Childrens Hospital at OU Health
Oklahoma City, Oklahoma, United States

University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States

Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States

Rhode Island Hospital
Providence, Rhode Island, United States

The Miriam Hospital-Clinical Trials
Providence, Rhode Island, United States

Coastal Pediatric Research
Summerville, South Carolina, United States

Avera McKennan Hospital & University Health Center
Sioux Falls, South Dakota, United States

Avera Research Institute - Sioux Falls
Sioux Falls, South Dakota, United States

Le Bonheur Children's Hospital
Memphis, Tennessee, United States

Le Bonheur Children's Hospital
Memphis, Tennessee, United States

Texas Children's Hospital
Houston, Texas, United States

Biopharma Informatic, LLC
McAllen, Texas, United States

Consano Clinical Research, LLC
Shavano Park, Texas, United States

University of Utah
Salt Lake City, Utah, United States

Childrens Hospital of The Kings Daughters
Norfolk, Virginia, United States

МHAT "Sveti Ivan Rilski" Gorna Oryahovitsa
Gorna Oryahovitsa, Bulgaria

Diagnostic-Consultative Center I Lom EOOD
Lom, Bulgaria

DCC Sveti Georgi EOOD
Plovdiv, Bulgaria

"Specialized Hospital for Active Treatment of Pneumo-Physiatric Diseases Dr. Dimitar Gramatikov -
Ruse, Bulgaria

Medical Center-1-Sevlievo EOOD
Sevlievo, Bulgaria

DCC "Alexandrovska"
Sofia, Bulgaria

Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases Vratsa EOOD
Vratsa, Bulgaria

Markhot Ferenc Oktatokorhaz es Rendelointezet
Eger, Heves, Hungary

Debreceni Egyetem Klinikai Kozpont
Debrecen, Hungary

Debreceni Egyetem Klinikai Központ
Debrecen, Hungary

Tokyo Metropolitan Children's Medical Center
Fuchu, Tokyo, Japan

Osaka City General Hospital
Osaka, Japan

Instituto Nacional de Pediatria
Mexico City, Distrito Federal, Mexico

Hospital Infantil de Mexico Federico Gomez
Mexico City, Distrito Federal, Mexico

JM Research SC
Cuernavaca, Morelos, Mexico

Eukarya PharmaSite S.C.
Monterrey, Nuevo LEON, Mexico

Eukarya Pharmasite S.C.
Monterrey, Nuevo LEON, Mexico

Tecnologico de Monterrey
Monterrey, Nuevo LEÓN, Mexico

Kohler & Milstein Research S.A. De C.V.
Merida, Yucatan, Mexico

Centro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatán S.
Merida, Yucatán, Mexico

Unidad de Atención Médica e Investigación en Salud
Mérida, Yucatán, Mexico

Centenario Hospital Miguel Hidalgo
Aguascalientes, Mexico

Sociedad de Metabolismo y Corazon
Veracruz, Mexico

Arké SMO S.A de C.V
Veracruz, Mexico

Sociedad de Metabolismo y Corazon S.C.
Veracruz, Mexico

San Miguel Medical
Trujillo Alto, Puerto Rico

Worthwhile Clinical Trials
Benoni, Gauteng, South Africa

CRISMO Research Centre
Germiston, Gauteng, South Africa

Botho Ke Bontle Health Services
Pretoria, Gauteng, South Africa

Ndlovu Research Centre
Dennilton, Limpopo, South Africa

Limpopo Clinical Research Initiative
Thabazimbi, Limpopo, South Africa

St. George's Hospital
London, England, United Kingdom

University College London Hospital
London, London, CITY OF, United Kingdom

King's College Hospital
London, London, CITY OF, United Kingdom

Imperial College Healthcare NHS Trust
London, United Kingdom

Royal Manchester Children's Hospital
Manchester, United Kingdom

Contacts

Pfizer CT.gov Call Center
1-800-718-1021
ClinicalTrials.gov_Inquiries@pfizer.com

Pfizer CT.gov Call Center, Study Director
Pfizer

NCT Number
Keywords
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Pediatrics
MeSH Terms
COVID-19
Ritonavir
Nirmatrelvir